Gruber, Thomas

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2023 | 2022 | 2021 | 2020 | 2017


Aydin, Sidar; Pareja, Javier; Schallenberg, Vivianne M; Klopstein, Armelle; Gruber, Thomas; Page, Nicolas; Bouillet, Elisa; Blanchard, Nicolas; Liblau, Roland; Körbelin, Jakob; Schwaninger, Markus; Johnson, Aaron J; Schenk, Mirjam; Deutsch, Urban; Merkler, Doron; Engelhardt, Britta (2023). Antigen recognition detains CD8+ T cells at the blood-brain barrier and contributes to its breakdown. Nature communications, 14(1), p. 3106. Nature Publishing Group 10.1038/s41467-023-38703-2

von Werdt, Diego; Gungor, Bilgi; Barreto de Albuquerque, Juliana; Gruber, Thomas; Zysset, Daniel; Kwong Chung, Cheong K C; Corrêa-Ferreira, Antonia; Berchtold, Regina; Page, Nicolas; Schenk, Mirjam; Kehrl, John H; Merkler, Doron; Imhof, Beat A; Stein, Jens V; Abe, Jun; Turchinovich, Gleb; Finke, Daniela; Hayday, Adrian C; Corazza, Nadia and Mueller, Christoph (2023). Regulator of G-protein signaling 1 critically supports CD8+ TRM cell-mediated intestinal immunity. Frontiers in immunology, 14, p. 1085895. Frontiers Research Foundation 10.3389/fimmu.2023.1085895


Kremenovic, Mirela; Chan, Alfred A; Feng, Bing; Bäriswyl, Lukas; Robatel, Steve; Gruber, Thomas; Tang, Li; Lee, Delphine J; Schenk, Mirjam (2022). BCG hydrogel promotes CTSS-mediated antigen processing and presentation, thereby suppressing metastasis and prolonging survival in melanoma. Journal for immunotherapy of cancer, 10(6), e004133. BioMed Central 10.1136/jitc-2021-004133


Gruber, Thomas; Robatel, Steve; Kremenovic, Mirela; Bäriswyl, Lukas; Gertsch, Jürg; Schenk, Mirjam (2021). Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma. Cancers, 13(8) MDPI AG 10.3390/cancers13081934

Sadozai, Hassan; Acharjee, Animesh; Eppenberger-Castori, Serenella; Gloor, Beat; Gruber, Thomas; Schenk, Mirjam; Karamitopoulou Diamantis, Evanthia (2021). Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer. Frontiers in immunology, 12(643529), p. 643529. Frontiers Research Foundation 10.3389/fimmu.2021.643529


Gruber, Thomas; Kremenovic, Mirela; Sadozai, Hassan; Rombini, Nives; Baeriswyl, Lukas; Maibach, Fabienne; Modlin, Robert L; Gilliet, Michel; von Werdt, Diego; Hunger, Robert E.; Jafari, S. Morteza Seyed; Parisi, Giulia; Abril-Rodriguez, Gabriel; Ribas, Antoni; Schenk, Mirjam (2020). IL-32γ potentiates tumor immunity in melanoma. JCI insight, 5(18) JCI Insight 10.1172/jci.insight.138772

Storni, Federico; Zeltins, Andris; Balke, Ina; Heath, Matthew D; Kramer, Matthias F; Skinner, Murray A; Zha, Lisha; Rösti, Elisa; Engeroff, Paul; Muri, Lukas; von Werdt, Diego; Gruber, Thomas; Cragg, Mark; Mlynarczyk, Margrit; Kündig, Thomas M; Vogel, Monique; Bachmann, Martin (2020). Vaccine against peanut allergy based on engineered Virus-Like-Particles displaying single major peanut allergens. Journal of allergy and clinical immunology, 145(4), 1240-1253.e3. Elsevier 10.1016/j.jaci.2019.12.007

Kremenovic, Mirela; Rombini, Nives; Chan, Alfred A.; Gruber, Thomas; Bäriswyl, Lukas; Lee, Delphine J.; Schenk, Mirjam (2020). Characterization of a Myeloid Activation Signature that Correlates with Survival in Melanoma Patients. Cancers, 12(6), p. 1431. MDPI AG 10.3390/cancers12061431


Sadozai, Hassan Ahmed; Gruber, Thomas; Schenk, Mirjam (2017). Induction of effective anti-tumour immunity by targeting dendritic cells in vivo. Madridge Journal of Vaccines, 1(1), e1-e4. Madridge Publishers

Provide Feedback